| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,165 |
19,724 |
$691K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
2,427 |
1,910 |
$71K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,642 |
1,248 |
$60K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
422 |
367 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
653 |
593 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
489 |
429 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
108 |
100 |
$3K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
47 |
41 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
96 |
89 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
47 |
44 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
124 |
106 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
39 |
37 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13 |
13 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
18 |
16 |
$351.03 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
38 |
37 |
$12.95 |
| 81003 |
|
14 |
12 |
$8.89 |